Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Tumori
|
October 31, 1983
5-Fluorouracil, vincristine and hydroxyurea combination chemotherapy in metastatic colorectal cancer
A M Liberati, F Di Costanzo, F Buzzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2003
Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in Italy
F Roila, E Ballatori, L Patoia, et al.
Tumori
|
February 28, 1985
Preliminary observation on the clinical tolerance of interferon-beta in cancer patients
A M Liberati, A Puxeddu, B Biscottini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Ondansetron
F Roila, M Tonato, C Basurto, et al.
Epidemiologia E Prevenzione
|
September 1, 1991
[The prevalence of stenosis of the internal carotid in subjects over 49: a population study]
S Ricci, F O Flamini, M Marini, et al.
Cancer Treatment Reports
|
December 1, 1985
Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research
F Roila, M Tonato, C Basurto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1987
Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research
F Roila, M Tonato, C Basurto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 1991
Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales
F Roila, M Lupattelli, M Sassi, et al.
American Journal of Clinical Oncology
|
June 1, 1991
Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study
F Roila, E Boschetti, M Tonato, et al.
Aging (Milan, Italy)
|
June 1, 1990
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test
L Parnetti, P Mecocci, C Neri, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Tumori
|
October 31, 1983
5-Fluorouracil, vincristine and hydroxyurea combination chemotherapy in metastatic colorectal cancer
A M Liberati, F Di Costanzo, F Buzzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2003
Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in Italy
F Roila, E Ballatori, L Patoia, et al.
Tumori
|
February 28, 1985
Preliminary observation on the clinical tolerance of interferon-beta in cancer patients
A M Liberati, A Puxeddu, B Biscottini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Ondansetron
F Roila, M Tonato, C Basurto, et al.
Epidemiologia E Prevenzione
|
September 1, 1991
[The prevalence of stenosis of the internal carotid in subjects over 49: a population study]
S Ricci, F O Flamini, M Marini, et al.
Cancer Treatment Reports
|
December 1, 1985
Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research
F Roila, M Tonato, C Basurto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1987
Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research
F Roila, M Tonato, C Basurto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 1991
Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales
F Roila, M Lupattelli, M Sassi, et al.
American Journal of Clinical Oncology
|
June 1, 1991
Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study
F Roila, E Boschetti, M Tonato, et al.
Aging (Milan, Italy)
|
June 1, 1990
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test
L Parnetti, P Mecocci, C Neri, et al.
Page
of 7